United States · FDA National Drug Code directory

mesalamine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68382-711_d9ce9589-6aee-4dc3-a71b-f1c32ab9f552
Product NDC: 68382-711
Form: TABLET, DELAYED RELEASE
Composition / generic term: mesalamine
Labeler: Zydus Pharmaceuticals USA Inc.
Marketing category: ANDA
Marketing start / end (source format): 20170619
Source listing expiry: 20261231

Source-listed ingredients

MESALAMINE — 1.2 g/1

These values do not establish equivalence or a dose recommendation.

Packages

120 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-711-19) · 68382-711-19
34 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-711-64) · 68382-711-64

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →